Gnosis by Lesaffre Enhances Vitamin K2 Offering with Acquisition of NattoPharma

Gnosis by Lesaffre Enhances Vitamin K2 Offering with Acquisition of NattoPharma

Share this article:

Gnosis-by-Lesaffre-Enhances-Vitamin-K2-Offering-with-Acquisiti

Gnosis by Lesaffre is expanding its capability as a global supplier of vitamin K2 with its acquisition of NattoPharma, another renowned supplier.

Vitamin K2 is an essential nutrient for optimal bone and cardiovascular health, but the modern diet does not include sufficient quantities of it. Only a few foods are naturally high in vitamin K2, such as natto, a Japanese fermented soybean dish, and these are not a mainstream part of diets in the United States or elsewhere. As a result, supplementation is necessary.

Gnosis by Lesaffre’s vitaMK7® and NattoPharma’s MenaQ7® solutions have been a part of formulations for nutraceutical and functional food products for over 10 years. This acquisition allows Gnosis by Lesaffre to offer to the market the most complete portfolio of solutions, adapted to each market need and able to satisfy all customers.

With the acquisition, the two players are coming together to expand their capabilities, their global reach, and to fuel future innovation as demand for vitamin K2 grows.

DISCOVER ALL OUR LATEST NEWS

CORPORATE HEADQUARTER
101 rue de Menin
59700 Marcq-en-Baroeul
France

Subscribe to our newsletter

The latest news, articles, and resources, sent to your inbox twice a month. 

The information provided here is, to the best of our knowledge, true and accurate. However, our products must only be used in compliance with local laws and regulations. We cannot guarantee the freedom of use for every intended application or country. These statements may not have been evaluated by your local Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease. A healthy, balanced and diversified diet should fulfill all nutritional needs.